Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E26.08 EPS (ttm)1.67 Insider Own0.04% Shs Outstand5.60B Perf Week5.92%
Market Cap241.99B Forward P/E12.68 EPS next Y3.43 Insider Trans-0.12% Shs Float5.59B Perf Month11.07%
Income9.40B PEG2.26 EPS next Q0.97 Inst Own66.70% Short Float1.10% Perf Quarter11.96%
Sales46.41B P/S5.21 EPS this Y-33.10% Inst Trans0.12% Short Ratio2.42 Perf Half Y19.90%
Book/sh12.29 P/B3.54 EPS next Y-8.10% ROA6.60% Target Price42.97 Perf Year17.50%
Cash/sh2.45 P/C17.71 EPS next 5Y11.53% ROE17.00% 52W Range32.79 - 43.08 Perf YTD18.04%
Dividend1.56 P/FCF48.79 EPS past 5Y2.20% ROI7.60% 52W High0.86% Beta0.72
Dividend %3.59% Quick Ratio1.20 Sales past 5Y-3.00% Gross Margin84.80% 52W Low32.51% ATR0.65
Employees78500 Current Ratio1.50 Sales Q/Q44.60% Oper. Margin22.70% RSI (14)82.30 Volatility1.79% 1.47%
OptionableYes Debt/Eq0.58 EPS Q/Q95.10% Profit Margin23.90% Rel Volume2.11 Prev Close42.10
ShortableYes LT Debt/Eq0.52 EarningsJul 28 BMO Payout76.90% Avg Volume25.28M Price43.45
Recom2.60 SMA208.07% SMA509.41% SMA20016.17% Volume53,302,371 Change3.21%
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jul-28-21 11:03PM  
06:41PM  
04:13PM  
04:13PM  
03:46PM  
03:45PM  
03:26PM  
02:29PM  
02:21PM  
02:14PM  
01:51PM  
01:47PM  
12:55PM  
12:48PM  
12:03PM  
10:59AM  
10:30AM  
10:14AM  
10:09AM  
09:56AM  
09:37AM  
08:50AM  
08:39AM  
08:11AM  
08:05AM  
08:01AM  
07:52AM  
07:35AM  
07:06AM  
06:53AM  
06:48AM  
06:45AM  
05:52AM  
03:00AM  
02:52AM  
02:05AM  
Jul-27-21 10:27PM  
05:37PM  
04:31PM  
02:12PM  
12:08PM  
11:55AM  
11:14AM  
09:52AM  
05:52AM  
04:19AM  
02:52AM  
Jul-26-21 09:44PM  
05:44PM  
03:59PM  
02:50PM  
02:08PM  
01:56PM  
01:05PM  
12:38PM  
12:00PM  
11:40AM  
11:06AM  
09:20AM  
06:00AM  
05:55AM  
03:55AM  
03:53AM  
Jul-25-21 10:36PM  
06:31PM  
09:26AM  
06:45AM  
Jul-24-21 06:04AM  
06:00AM  
Jul-23-21 10:57PM  
01:53PM  
12:55PM  
11:43AM  
11:31AM  
11:22AM  
11:06AM  
10:58AM  
10:09AM  
09:51AM  
09:33AM  
08:01AM  
07:03AM  
06:54AM  
06:49AM  
06:45AM  
06:16AM  
06:02AM  
06:00AM  
01:37AM  
12:33AM  
Jul-22-21 07:06PM  
07:01PM  
04:12PM  
03:21PM  
03:00PM  
02:36PM  
12:16PM  
11:10AM  
10:28AM  
10:20AM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5413,000501,08513,000Aug 10 08:07 AM